Literature DB >> 2204049

Crystallographic consequences of molecular dissymmetry.

H G Brittain1.   

Abstract

The molecular chirality associated with an optically active molecule is manifested in the bulk crystallography of the compound. The historical development of optical activity was greatly aided by systematic studies of the habits of enantiomorphic crystals. The concepts of molecular dissymmetry, crystallography, and chirality are therefore linked. Racemic materials can be characterized by means of their melting-point phase diagrams, and this information used to design rational separations of racemic mixtures into their component enantiomers. Certain compounds are found to resolve spontaneously upon crystallization, and the enantiomers of these conglomerate species may be separated by direct crystallization. Compounds which crystallize as true racemates require resolution through the formation and separation of dissociable diastereomer species. The choice of resolution pathway is therefore determinable through an evaluation of the melting-point phase diagrams. When possible, resolution through direct crystallization represents the simplest, most cost-effective means of enantiomer resolution.

Mesh:

Year:  1990        PMID: 2204049     DOI: 10.1023/a:1015851118787

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  4 in total

Review 1.  Enantioselective aspects of drug action and disposition: therapeutic pitfalls.

Authors:  F Jamali; R Mehvar; F M Pasutto
Journal:  J Pharm Sci       Date:  1989-09       Impact factor: 3.534

2.  The FDA perspective on the development of stereoisomers.

Authors:  W H De Camp
Journal:  Chirality       Date:  1989       Impact factor: 2.437

3.  The crystal and molecular structure of (2-Hydroxyphenyl) alanine (o-Tyrosine).

Authors:  A Mostad; C Rømming; L Tressum
Journal:  Acta Chem Scand B       Date:  1975

Review 4.  Stereoselectivity of bioactive xenobiotics. A pre-Pasteur attitude in medicinal chemistry, pharmacokinetics and clinical pharmacology.

Authors:  E J Ariëns; E W Wuis; E J Veringa
Journal:  Biochem Pharmacol       Date:  1988-01-01       Impact factor: 5.858

  4 in total
  6 in total

1.  Formation of the racemic compound of ephedrine base from a physical mixture of its enantiomers in the solid, liquid, solution, or vapor state.

Authors:  S P Duddu; D J Grant
Journal:  Pharm Res       Date:  1992-08       Impact factor: 4.200

2.  Simultaneous quantification of an enantiomer and the racemic compound of ibuprofen by X-ray powder diffractometry.

Authors:  N V Phadnis; R Suryanarayanan
Journal:  Pharm Res       Date:  1997-09       Impact factor: 4.200

3.  Relationship among physicochemical properties, skin permeability, and topical activity of the racemic compound and pure enantiomers of a new antifungal.

Authors:  L Wearley; B Antonacci; A Cacciapuoti; S Assenza; I Chaudry; C Eckhart; N Levine; D Loebenberg; C Norris; R Parmegiani
Journal:  Pharm Res       Date:  1993-01       Impact factor: 4.200

4.  Effects of configuration around the chiral carbon atoms on the crystal properties of ephedrinium and pseudoephedrinium salicylates.

Authors:  S P Duddu; D J Grant
Journal:  Pharm Res       Date:  1994-11       Impact factor: 4.200

5.  Stereoselective dissolution of propranolol hydrochloride from hydroxypropyl methylcellulose matrices.

Authors:  S P Duddu; M Vakilynejad; F Jamali; D J Grant
Journal:  Pharm Res       Date:  1993-11       Impact factor: 4.200

6.  Models for Cooperative Catalysis: Oxidative Addition Reactions of Dimethylplatinum(II) Complexes with Ligands Having Both NH and OH Functionality.

Authors:  Mahmood Azizpoor Fard; Ava Behnia; Richard J Puddephatt
Journal:  ACS Omega       Date:  2019-01-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.